1. Home
  2. LXRX vs KELYB Comparison

LXRX vs KELYB Comparison

Compare LXRX & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.42

Market Cap

990.6M

Sector

Health Care

ML Signal

HOLD

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

HOLD

Current Price

$23.47

Market Cap

814.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXRX
KELYB
Founded
1995
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
990.6M
814.8M
IPO Year
2000
1994

Fundamental Metrics

Financial Performance
Metric
LXRX
KELYB
Price
$2.42
$23.47
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.15
N/A
AVG Volume (30 Days)
2.8M
985.0
Earning Date
05-01-2026
05-07-2026
Dividend Yield
N/A
1.95%
EPS Growth
77.78
N/A
EPS
N/A
0.15
Revenue
$49,803,000.00
$5,355,600,000.00
Revenue This Year
N/A
$0.72
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$146.67
Revenue Growth
60.24
N/A
52 Week Low
$1.03
$8.38
52 Week High
$2.68
$125.00

Technical Indicators

Market Signals
Indicator
LXRX
KELYB
Relative Strength Index (RSI) 54.87 48.37
Support Level $2.01 $21.49
Resistance Level $2.50 $24.78
Average True Range (ATR) 0.15 0.65
MACD -0.01 -0.21
Stochastic Oscillator 81.14 41.74

Price Performance

Historical Comparison
LXRX
KELYB

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

Share on Social Networks: